The soluble form, sLOX-1, is released into circulation upon cleavage of the membrane-bound receptor, with elevated serum levels observed in patients with acute coronary syndrome (ACS) and other cardiovascular disorders. This evidence concerns the gene OLR1 and cardiovascular disorder.